Every SEC Form 3/4/5 on record for this filer (CIK 1398815) — 5 issuers, 58 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CYRX | Cryoport, Inc. | Director | 2015-11-24 → 2026-06-08 | 22 | −$541,062 |
| CELU | Celularity Inc | Chief Executive Officer · Director | 2021-07-16 → 2026-04-15 | 16 | $3M |
| BIVI | BIOVIE INC. | Director | 2021-09-28 → 2025-01-07 | 6 | — |
| MYOS | MYOS RENS TECHNOLOGY INC. | Director · lapsed | 2015-07-27 → 2020-04-06 | 11 | $122,289 |
| BNKL | Bionik Laboratories Corp. | Director · lapsed | 2015-12-16 → 2015-12-16 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| CYRX | 2025-09-11 | Sell | 25,000 | $9.71 | $242,750 | 51,275 |
| CYRX | 2025-08-22 | Sell | 5,000 | $8.60 | $43,000 | 26,275 |
| CYRX | 2025-05-28 | Sell | 12,500 | $6.10 | $76,250 | 8,061 |
3 of 5 issuers are covered and open a security page; the rest are on file here only.
